|
|
Volumn 27, Issue 9, 2009, Pages 784-786
|
|
PARP inhibitors blaze a trail in difficult-to-treat cancers
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AG 14699;
AZD2281;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
BSI 201;
CARBOPLATIN;
CISPLATIN;
GEMCITABINE;
IMATINIB;
INO 1001;
MK 4827;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
O (2 HYDROXY 3 PIPERIDINOPROPYL)NICOTINIC AMIDOXIME;
OLAPARIB;
UNCLASSIFIED DRUG;
ZINC FINGER PROTEIN;
ABSENCE OF SIDE EFFECTS;
ANTINEOPLASTIC ACTIVITY;
AORTA ANEURYSM;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DOUBLE STRANDED DNA BREAK;
DRUG RESEARCH;
DRUG SPECIFICITY;
ENDOMETRIUM CANCER;
GENE MUTATION;
GENE OVEREXPRESSION;
GENOMIC INSTABILITY;
GLIOBLASTOMA;
HUMAN;
MELANOMA;
NEOPLASM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
NOTE;
OVARY CANCER;
PRIORITY JOURNAL;
PROSTATE CANCER;
SINGLE STRANDED DNA BREAK;
SOLID TUMOR;
TREATMENT INDICATION;
TRIPLE NEGATIVE BREAST CANCER;
UPREGULATION;
ZINC FINGER MOTIF;
ANTINEOPLASTIC AGENTS;
DRUG INDUSTRY;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
MODELS, MOLECULAR;
NEOPLASMS;
POLY(ADP-RIBOSE) POLYMERASES;
|
|
EID: 70249091814
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0909-784 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|
